drugset / Trial / NCT00030069

Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes

NCT00030069

Phase 2 Completed 32 enrolled University of Pittsburgh
Non-randomizedOpen-labelTreatment

Summary

This is a study to determine the response rate in patients with myelodysplastic syndromes treated with calcitriol and dexamethasone.

Timeline

Start
2001-09
Primary completion
2007-09
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcitriol Small molecule
Subject Dexamethasone Small molecule